At this time, posts about Genexine are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 43,000 shares of Genexine, while institutions have sold a net 17,000 shares. Genexine is known as a company specializing in the development of biopharmaceuticals.
As of 11:30 AM on the 18th, Genexine's stock price is 160,900 KRW, down 3.65% from the previous day, with a trading volume of 716,161 shares, which is 143.56% of the 5-day average trading volume.
In addition to Genexine, posts by investors are also rapidly increasing for Unison (018000), DB HiTek1 Preferred (000995), and Easywell (090850).
※Source: AI Investment Assistant AI Rassi
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
